FI102681B - Menetelmä glykoproteiinin valmistamiseksi - Google Patents

Menetelmä glykoproteiinin valmistamiseksi

Info

Publication number: FI102681B
Authority: FI; Finland
Prior art keywords: glycoprotein; cells; preparation; fibroblasts; accelerating
Prior art date: 1989-03-10

Application number

FI914234A

Other languages

English (en)

Swedish (sv)

Other versions

FI102681B1 (fi

FI914234A0 (fi

Inventor

Higashio Kanji

Mitsura Shinjiro

Shima Nobuyuki

Itagaki Yasuharu

Nagao Masaya

Original Assignee

Daiichi Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-10

Filing date

1991-09-09

Publication date

1999-01-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26340889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI102681(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-09-09 Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co

1991-09-09 Publication of FI914234A0 publication Critical patent/FI914234A0/fi

1999-01-29 Application granted granted Critical

1999-01-29 Publication of FI102681B1 publication Critical patent/FI102681B1/fi

1999-01-29 Publication of FI102681B publication Critical patent/FI102681B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

FI914234A 1989-03-10 1991-09-09 Menetelmä glykoproteiinin valmistamiseksi FI102681B (fi)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP5863189		1989-03-10
JP669290		1990-01-16
PCT/JP1990/000314 WO1990010651A1 (fr)	1989-03-10	1990-03-09	Glycoproteine humaine, facteur physiologiquement actif la contenant, et preparation pharmaceutique le contenant en tant qu'ingredient actif

Publications (3)

Publication Number	Publication Date
FI914234A0 FI914234A0 (fi)	1991-09-09
FI102681B1 FI102681B1 (fi)	1999-01-29
FI102681B true FI102681B (fi)	1999-01-29

Family

ID=26340889

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI914234A FI102681B (fi)	1989-03-10	1991-09-09	Menetelmä glykoproteiinin valmistamiseksi

Country Status (17)

Country	Link
US (2)	US5587359A (fi)
EP (1)	EP0462277B1 (fi)
JP (1)	JPH0768272B1 (fi)
KR (1)	KR960009054B1 (fi)
AT (1)	ATE123498T1 (fi)
AU (1)	AU629314B2 (fi)
CA (1)	CA2049017C (fi)
DE (1)	DE69019962T2 (fi)
DK (1)	DK0462277T3 (fi)
ES (1)	ES2075199T3 (fi)
FI (1)	FI102681B (fi)
HU (2)	HU212513B (fi)
IE (1)	IE64005B1 (fi)
NO (1)	NO180796C (fi)
NZ (1)	NZ232813A (fi)
RU (1)	RU2113480C1 (fi)
WO (1)	WO1990010651A1 (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5362716A (en) *	1989-12-27	1994-11-08	The United States Of America As Represented By The Department Of Health And Human Services	Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
EP0859009B1 (en) *	1990-06-11	2005-11-30	Toshikazu Nakamura	Recombinant human hepatocyte growth factor and method for production thereof
ATE178354T1 (de) *	1990-07-13	1999-04-15	Snow Brand Milk Products Co Ltd	Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung
EP0571387B1 (en) *	1990-09-14	2003-12-17	THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce	A non-mitogenic competitive hgf antagonist
US5821223A (en) *	1990-09-14	1998-10-13	The United States Of America As Represented By The Department Of Health And Human Services	Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
JP3200609B2 (ja) *	1990-12-28	2001-08-20	敏一中村	上皮細胞増殖促進剤
JPH0597A (ja) *	1991-06-21	1993-01-08	Snow Brand Milk Prod Co Ltd	新規抗ｔｃｆ−ｉｉモノクローナル抗体及びそれを用いるｔｃｆ−ｉｉの測定方法
CA2100720C (en)	1992-07-16	2003-03-11	Hiroaki Masunaga	Medicinal composition comprising tcf-ii
DK0653211T3 (da) *	1992-07-16	2002-05-06	Daiichi Seiyaku Co	Blodkoagulationsnormalisator indeholdende TCF-II som aktiv bestanddel
CA2130561A1 (en) *	1992-12-28	1994-07-07	Kyoji Yamaguchi	Modified tcf
JP3552240B2 (ja) *	1993-02-23	2004-08-11	第一製薬株式会社	高濃度ｔｃｆ製剤
US5837676A (en) *	1993-10-18	1998-11-17	Long Island Jewish Medical Center	Use of scatter factor to enhance angiogenesis
JP2747979B2 (ja) *	1994-08-19	1998-05-06	雪印乳業株式会社	ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬
JPH08176007A (ja) *	1994-12-27	1996-07-09	Snow Brand Milk Prod Co Ltd	脂質代謝異常治療剤
WO1996020214A1 (en) *	1994-12-27	1996-07-04	Snow Brand Milk Products Co., Ltd.	Tcf mutant
AU4027601A (en) *	1995-07-11	2001-07-26	Snow Brand Milk Products Co., Ltd.	Lyophilized HGF preparations
JP3927248B2 (ja) *	1995-07-11	2007-06-06	第一製薬株式会社	Ｈｇｆ凍結乾燥製剤
JP4006058B2 (ja)	1997-03-11	2007-11-14	第一三共株式会社	多臓器不全予防及び／又は治療剤
EP0950416B1 (en) *	1997-03-14	2006-11-02	Daiichi Pharmaceutical Co., Ltd.	Use of TCF-II for the treatment of cancer related body weight loss, anaemia and TNF elevation
JPH1129493A (ja) *	1997-07-14	1999-02-02	Snow Brand Milk Prod Co Ltd	放射線障害予防及び／又は治療剤
JPH11269091A (ja) *	1998-03-19	1999-10-05	Snow Brand Milk Prod Co Ltd	敗血症予防及び／又は治療剤
CN1352087A (zh) *	2000-11-02	2002-06-05	上海博德基因开发有限公司	一种新的多肽——人糖蛋白42和编码这种多肽的多核苷酸
KR100562824B1 (ko) *	2002-03-20	2006-03-23	주식회사 바이로메드	유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
US7563810B2 (en)	2002-11-06	2009-07-21	Celgene Corporation	Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en)	2002-11-06	2011-10-11	Celgene Corporation	Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
CN100417412C (zh) *	2003-03-28	2008-09-10	威海赛洛金药业有限公司	促肝细胞生长素注射液及制备方法和应用
JP4728807B2 (ja) *	2003-09-03	2011-07-20	敏一中村	ヒト組換えｈｇｆを含有する皮膚潰瘍予防治癒剤
CA2640010A1 (en) *	2006-01-25	2007-08-02	Octapharma Ag	Purification and use of a factor for supporting wound healing
WO2008136183A1 (ja) *	2007-04-28	2008-11-13	Applied Cell Biotechnologies, Inc.	皮膚または歯肉の軟組織の欠損を補修するための組成物，及び自己線維芽細胞の培養方法
US20090202606A1 (en) *	2008-01-25	2009-08-13	Viromed Co., Ltd.	Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
ES2556711T3 (es) *	2008-04-09	2016-01-19	Viromed Co., Ltd.	Formulaciones liofilizadas de ADN para el aumento de la expresión del ADN plasmídico
MX375916B (es)	2013-10-22	2025-03-07	Helixmith Co Ltd	Composicion para prevenir o tratar la esclerosis lateral amiotrofica usando dos o mas isoformas del factor de crecimiento de hepatocito.
WO2015166885A1 (ja) *	2014-04-28	2015-11-05	エーザイ・アール・アンド・ディー・マネジメント株式会社	Ｈｇｆ凍結乾燥製剤
JP6281992B2 (ja)	2014-09-10	2018-02-21	クリングルファーマ株式会社	神経疾患の治療に適したｈｇｆ製剤
JP6861201B2 (ja)	2016-03-17	2021-04-21	エーザイ・アール・アンド・ディー・マネジメント株式会社	活性型肝細胞増殖因子（ｈｇｆ）の製造方法
JP7212230B2 (ja)	2018-07-19	2023-01-25	ヘリックスミスカンパニー，リミテッド	ネイキッドｄｎａ遺伝子療法のための凍結乾燥した薬剤学的組成物
AU2022272740A1 (en)	2021-05-14	2023-11-02	Claris Biotherapeutics, Inc.	Compositions of growth factor for the treatment of eye disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS58148826A (ja) *	1982-02-26	1983-09-05	Mochida Pharmaceut Co Ltd	糖蛋白質および腫瘍治療剤
JP2564486B2 (ja) *	1986-07-14	1996-12-18	修治橋本	肝細胞増殖因子
US5037644A (en) *	1986-10-27	1991-08-06	Cetus Corporation	Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
DE3643182A1 (de) *	1986-12-18	1988-06-30	Behringwerke Ag	Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4
JPS6410998A (en) *	1986-12-22	1989-01-13	Green Cross Corp	Tumor cell inhibitory factor
JPS63243032A (ja) *	1987-03-27	1988-10-07	Green Cross Corp:The	トロンビンの加熱処理方法
DE3729863A1 (de) *	1987-09-05	1989-03-16	Boehringer Mannheim Gmbh	Stabilisierte erythropoietin-lyophilisate
JPH0741891B2 (ja) *	1987-08-26	1995-05-10	凸版印刷株式会社	容器素材成形装置
FI80741C (fi) *	1987-10-29	1990-07-10	Laennen Tehtaat Oy	Modifierat papper.
ATE178354T1 (de) *	1990-07-13	1999-04-15	Snow Brand Milk Products Co Ltd	Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung

1990
- 1990-03-06 NZ NZ232813A patent/NZ232813A/en unknown
- 1990-03-09 CA CA002049017A patent/CA2049017C/en not_active Expired - Lifetime
- 1990-03-09 RU RU95110767A patent/RU2113480C1/ru active
- 1990-03-09 AT AT90904429T patent/ATE123498T1/de not_active IP Right Cessation
- 1990-03-09 DK DK90904429.9T patent/DK0462277T3/da active
- 1990-03-09 AU AU51774/90A patent/AU629314B2/en not_active Expired
- 1990-03-09 KR KR1019910701058A patent/KR960009054B1/ko not_active IP Right Cessation
- 1990-03-09 DE DE69019962T patent/DE69019962T2/de not_active Expired - Lifetime
- 1990-03-09 EP EP90904429A patent/EP0462277B1/en not_active Expired - Lifetime
- 1990-03-09 IE IE86390A patent/IE64005B1/en not_active IP Right Cessation
- 1990-03-09 ES ES90904429T patent/ES2075199T3/es not_active Expired - Lifetime
- 1990-03-09 WO PCT/JP1990/000314 patent/WO1990010651A1/ja active IP Right Grant
- 1990-03-09 HU HU902330A patent/HU212513B/hu unknown
- 1990-03-09 JP JP2504271A patent/JPH0768272B1/ja not_active Expired - Lifetime
1991
- 1991-09-09 NO NO913546A patent/NO180796C/no not_active IP Right Cessation
- 1991-09-09 FI FI914234A patent/FI102681B/fi active
1994
- 1994-09-12 US US08/304,419 patent/US5587359A/en not_active Expired - Lifetime
1995
- 1995-06-02 HU HU95P/P00149P patent/HU211229A9/hu unknown
1996
- 1996-03-19 US US08/617,621 patent/US6333309B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
FI102681B1 (fi)	1999-01-29
EP0462277A1 (en)	1991-12-27
WO1990010651A1 (fr)	1990-09-20
KR960009054B1 (ko)	1996-07-10
DE69019962T2 (de)	1995-11-23
EP0462277A4 (en)	1992-08-12
AU5177490A (en)	1990-10-09
ES2075199T3 (es)	1995-10-01
DE69019962D1 (de)	1995-07-13
HU211229A9 (en)	1995-11-28
NZ232813A (en)	1992-08-26
DK0462277T3 (da)	1995-10-30
IE64005B1 (en)	1995-06-28
NO913546L (no)	1991-11-11
US6333309B1 (en)	2001-12-25
HU212513B (en)	1996-07-29
NO180796C (no)	1997-06-25
EP0462277B1 (en)	1995-06-07
RU2113480C1 (ru)	1998-06-20
JPH0768272B1 (fi)	1995-07-26
FI914234A0 (fi)	1991-09-09
KR920701256A (ko)	1992-08-11
ATE123498T1 (de)	1995-06-15
HU902330D0 (en)	1991-12-30
NO180796B (no)	1997-03-17
CA2049017C (en)	1998-10-27
IE900863L (en)	1990-09-10
NO913546D0 (no)	1991-09-09
RU95110767A (ru)	1997-06-10
US5587359A (en)	1996-12-24
CA2049017A1 (en)	1990-09-11
HUT58797A (en)	1992-03-30
AU629314B2 (en)	1992-10-01

Publication	Publication Date	Title
FI102681B (fi)	1999-01-29	Menetelmä glykoproteiinin valmistamiseksi
GR3035627T3 (en)	2001-06-29	A mammalian cytokine, il-11.
CS40289A3 (en)	1992-01-15	Method of vital viral cultures maintenance
DE69027990D1 (de)	1996-09-05	Kultur des wachstumsfaktors der vaskularen endothelialzellen und dns, die dafür kodiert
ES2018654T5 (es)	1995-08-16	Catalizador de polimerizacion.
DE3586697D1 (en)	1992-11-05	Aktive thymopentin-analoga.
DK0789588T3 (da)	2005-05-30	Metode til fremstilling af et medikament til behandling af sekundær immundefekt
EP0314415A3 (en)	1990-05-30	Interleukin-7
IT1180161B (it)	1987-09-23	Procedimento e prodotti per la rivelazione del virus della leucemia delle cellule umane t.
DE3788796D1 (de)	1994-02-24	Serumfreies medium zur proliferation von lymphokin-aktivierten töterzellen.
WO1987007640A1 (en)	1987-12-17	Process for preparing neuraminidase
IL72571A0 (en)	1984-11-30	Process for the maintenance and proliferation of virus genomes and derivatives thereof
AU591290B2 (en)	1989-11-30	Rapid detection of n. gonorrhoeae without culture
IL81751A0 (en)	1987-10-20	Fermentation of bacteria at high productivities
RO92552B1 (ro)	1987-10-01	Procedeu de obtinere a unei compozitii acrilice
ATE100137T1 (de)	1994-01-15	Serumfreies medium zur proliferation von lymphokin-aktivierten toeterzellen.
MX9802380A (es)	1998-08-30	Formas cortas de quimiocina beta-8.

Legal Events

Date	Code	Title	Description
2009-05-22	PC	Transfer of assignment of patent	Owner name: ATLAS PHARMACEUTICALS INC. Free format text: ATLAS PHARMACEUTICALS INC.

Date

Code

Title

Description

2009-05-22

Transfer of assignment of patent

Owner name: ATLAS PHARMACEUTICALS INC.

Free format text: ATLAS PHARMACEUTICALS INC.